Artikel ; Online: Sars-CoV-2: A clinical update - II.
Revista da Associacao Medica Brasileira (1992)
2020 Band 66, Heft 4, Seite(n) 547–557
Abstract: Introduction: A covid-19 pandemic decreed by WHO has raised greater awareness of it.: Epidemiology: The infection, reached the mark of 2,000,000 patients in 33 countries and caused the risk of the presence of comorbidities and advanced age.: ... ...
Abstract | Introduction: A covid-19 pandemic decreed by WHO has raised greater awareness of it. Epidemiology: The infection, reached the mark of 2,000,000 patients in 33 countries and caused the risk of the presence of comorbidities and advanced age. Transmissibility: The transmissibility calculated so far is similar to the H1N1 epidemic, but with lower mortality rates. Physiopathology: The SARS-CoV-2 virus, of the Coronaviridae family, has the capacity for cellular invasion through the angiotensin-converting enzyme 2 does not have a lower respiratory epithelium and in the cells of the small intestine mucosa. Clinical manifestations: a presentation can be divided into mild (fever, fatigue, cough, myalgia, and sputum) and severe (cyanosis, dyspnoea, tachypnea, chest pain, hypoxemia and need for clinical measurement) and has an estimated estimate of 2%. Diagnosis: allows the detection of viral load in CRP-TR of patients with high clinical suspicion. Treatment: based on supportive measures and infection control. In severe cases, the use of medications such as hydroxychloroquine and azithromycin or medication can be promising. Take care to avoid the use of corticosteroids. There are no restrictions on the use of resources and IECAs / BRAs. |
---|---|
Mesh-Begriff(e) | Angiotensin-Converting Enzyme 2 ; Basic Reproduction Number ; Betacoronavirus ; COVID-19 ; Child ; Coronavirus Infections/diagnosis ; Coronavirus Infections/mortality ; Coronavirus Infections/physiopathology ; Coronavirus Infections/therapy ; Diagnosis, Differential ; Drug Therapy, Combination ; Humans ; Palliative Care/methods ; Pandemics ; Peptidyl-Dipeptidase A/metabolism ; Pneumonia, Viral/diagnosis ; Pneumonia, Viral/mortality ; Pneumonia, Viral/physiopathology ; Pneumonia, Viral/therapy ; SARS-CoV-2 |
Chemische Substanzen | Peptidyl-Dipeptidase A (EC 3.4.15.1) ; ACE2 protein, human (EC 3.4.17.23) ; Angiotensin-Converting Enzyme 2 (EC 3.4.17.23) |
Schlagwörter | covid19 |
Sprache | Englisch |
Erscheinungsdatum | 2020-06-22 |
Erscheinungsland | Brazil |
Dokumenttyp | Journal Article ; Review |
ZDB-ID | 731969-1 |
ISSN | 1806-9282 ; 0104-4230 ; 0004-5241 ; 0102-843X |
ISSN (online) | 1806-9282 |
ISSN | 0104-4230 ; 0004-5241 ; 0102-843X |
DOI | 10.1590/1806-9282.66.4.547 |
Datenquelle | MEDical Literature Analysis and Retrieval System OnLINE |
Zusatzmaterialien
Kategorien
Verfügbar in ZB MED Köln/Königswinter
Zs.B 654: Hefte anzeigen | Standort: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG) |
Über subito bestellen
Dieser Service ist kostenpflichtig (siehe Lieferbedingungen von subito). Bestellungen, die einen Artikel nebst Supplementary Material umfassen, werden grundsätzlich wie mehrfache Bestellungen bearbeitet. Gebühren fallen in diesen Fällen für jede einzelne Bestellung an.